These updates are listed according to the TAM Subgroup that ratifies them. The TAM Subgroup meets every 2 months.

'Latest updates' is a collection of those amendments that have been published while awaiting ratification at the next TAM Subgroup. 

December 2025 TAMSG

 

Major updates

To view the changes to the guidance, see the 'What's new' section of each guideline.


Minor updates

To view the changes to the guidance, see the 'What's new' section of each guideline.


Reviewed with no changes


Removed Guidance

    • Amputation pain (Raigmore in-patient) (Guidelines)

October 2025 TAMSG

*New Guidance* (ratified at previous TAMSG):


*Major updates* (ratified at previous TAMSG): 

To view the changes to the guidance, see the 'What's new' section of each guideline.


Minor updates (awaiting ratification at next TAMSG): 

To view the changes to the guidance, see the 'What's new' section of each guideline.


Reviewed with no changes: 


Removed Guidance:

  • Proton pump inhibitor (PPI) selection and administration in children (Paediatric Guidelines) - Guidance reviewed and incorporated into TAM336 Infant feeding difficulties.
  • Lyme disease (Antimicrobial). Removed and content incorporated into Lyme disease (Guidelines)
  • HIV referral pathway (Guidelines). Replaced and incorporated into: Human immunodeficiency virus (HIV) (Guidelines) | Right Decisions
  • HIV instant home testing pathway (Guidelines). Replaced and incorporated into: Human immunodeficiency virus (HIV) (Guidelines) | Right Decisions
  • COVID-19: Oxygen flowcharts (Guidelines)
  • COVID-19: Patient information
  • COVID-19: Fingers & Toes (Guidelines)
  • COVID-19: Trial medication (Guidelines)

August 2025 TAMSG

New Guidance: 

Updated Guidance: 

To view the changes to the guidance, see the 'What's new' section of each guideline.

Removed guidance:

February 2025 TAMSG

New Guidance: 

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Guidance reviewed with no changes:

Guidance removed and archived:

  • COVID-19: When to refer to Infectious Diseases Team (In-patient) (Guidelines)
  • COVID-19: Aerosol Generating Procedures (Guidelines) 
  • Sleep onset difficulties (Paediatric Guidelines)
  • CKD: Screening and diagnosis & CKD: Management. These have been combined into the one CKD guideline. 
  • TAM515: Lymphoedema, Assessing vascular status (Guidelines) Guideline not developed as awaiting national guidance. 

2024

January 2024

Updated Guidance


February 2024

Updated guidance

Removed guidance

  • Introduction to treatment of low electrolytes as the information is within the guidance

March 2024

New guidance

  • Haematology Full guideline suite reviewed with updates to guidelines and new guidelines added: 
    • Thrombocytopenia
    • Neutropenia
    • Neutrophilia
    • Lymphocytosis
    • Eosinophilia
    • Basophilia
    • Monocytosis
    • Splenomegaly
    • Lymphadenopathy
    • Elevated plasma viscosity
    • Iron deficiency
    • Hyperferritinaemia
    • Abnormal coagulation screen and bruising
    • VTE and travel
    • Blood parasite investigation
  • ADHD Guidelines

Updated guidance

Removed guidance

  • ADHD Pilot Pathway 
  • Post partum haemorrhage 
  • Physical monitoring with mental health

April 2024

New Guidance

Updated Guidance (with changes)

Updated Guidance (no changes)

Removed Guidance 

  • COVID115 Management of surgical patients who decline a COVID19 test
  • AMT136 Prophylaxis following tick bite
  • AMT137 Erythema migrans (EM) and/or non-focal symptoms (eg 'flu-like' symptoms)
  • AMT138 Lyme disease affecting the cranial nerves or peripheral nervous system
  • AMT139 Lyme disease affecting the central nervous system
  • AMT140 Lyme disease arthritis, Acrodermatitis chronic atrophicans
  • AMT141 Lyme carditis: haemodynamically stable
  • AMT142 Lyme carditis: haemodynamically unstable

May 2024

New Guidance:

Updated Guidance: 

Removed Guidance:

  • Anticoagulant recommendations. This is replaced with: Warfarin.

June 2024

New guidance:

Updated guidance: 

Guidance reviewed with no changes: 

Removed guidance: 

  • Referral to clinical Psychology (Guidelines)
  • Orlistat Frequently Asked Questions (Patient information)
  • Bariatric Surgery Frequently Asked Questions (Patient information)
  • Non-steroidal anti-inflammatory drugs (NSAIDS) (Guidelines)
  • Self Help Service - patient information leaflet (Guidelines)

July 2024

New guidance: 

Updated Guidance: 

To view the changes to guidance, see the 'What's new' section of each guideline. 

Removed guidance: 

  • Hospital in-patients admitted with symptomatic COVID-19 infection (Guidelines)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection (Guidelines)
  • Highest Risk List: COVID-19 (Guidelines):
    Replaced by: Risk factors for progression to severe COVID-19 infection | Right Decisions (scot.nhs.uk)
  • Community Pharmacy (Resources):
    Archived as information now available on CP website. 
  • Allergy (Paediatric guidelines):
    Replaced by Food allergy referral and Egg allergy guidelines. 
  • Epidural (Paediatric Guidelines) | Right Decisions (scot.nhs.uk)

August 2024

New Guidance:

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline. 

Guidance reviewed with no changes:


September 2024

New guidance: 

Updated guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Archived guidance: 


October 2024

Updated guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.

Guidance updated with no amendments:

Guidance removed and archived:

  • Polyarthritis / Polyarthropathy

November 2024

New Guidance:

Updated Guidance:

To view the changes to the guidance, see the 'What's new' section of each guideline.


December 2024

Included in Feb 2025 updates. 

2023

January 2023:

New guidance

  • TAM535 ADHD pilot pathway

Amended guidance 

  • TAM528 Delirium management
  • TAM281 Parkinsons disease
  • TAM148 Achieving control in type 2 diabetes
  • TAM481 Giant cell arthritis (GCA)
  • TAM331 Non-IgE Cows Milk Protein Allergy Guidance 
  • TAM135 Acute coronary care syndrome
  • AMT101 Amikacin
  • AMT152 Influenza treatment
  • Urinary tract (UTI)
  • TAM508 Pre-Diabetes and type 2 referrals

Removed guidance 

  • COVID078 Emergency management of tracheostomy patient on LTV 
  • COVID019 Rheumatology COVID-19
  • COVID102 Anticoagulant COVID-19
  • COVID004 Cancer COVID-19
  • COVID052 End of life Acute COVID-19
  • COVID006 Diabetes COVID-19 
  • TAM302 Management following colposcopy 
  • TAM299 Cervical smear recall 
  • TAM387 Incontinence dermatitis
  • FCR110 Inner Moray Firth Investigation and Treatment Room Service 
  • COVID021 SKIN COVID-19
  • COVID020 Sexual Health
  • COVID013 Mental Health COVID-19

February 2023:

NB this section is being updated on a daily basis throughout the month.

New guidance

  • Refugee and asylum seeker support
  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure

Amended guidance 

  • TAM310 GP Out of Hours HSCP
  • COVID111 Non hospitalised patients with symptomatic COVID-19 infection 
  • COVID039 Aeroso generating procedures
  • TAM185 Ophthalmology diagnosis/flowcharts 
  • TAM148 Achieving control in type 2 diabetes 
  • TAM UTI guidance 

March 2023:

New guidance

  • ADHD pilot pathway

Updated guidance

  • Stress and distress in dementia

Removed guidance

  • Incontinence dermatitis
  • Skin COVID-19
  • Sexual Health COVID-19

April 2023:

New guidance

  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure
  • VTEP guidance: New Craigs

Updated guidance

  • Aerosol generating procedures COVID-19
  • Eyes
  • Genital tract
  • Highest Risk List: COVID-19
  • HIV pre-exposure prophylaxis PrEP
  • Infective endocarditis
  • Influenza treatment
  • Microbiology susceptibility reporting
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Smoking cessation
  • Ultrasound referral guidelines
    • Neck lump added

Removed guidance

  • Long term ventilation: Primary Care: COVID-19

May 2023:

New guidance

  • ECG monitoring of patient on drugs known to prolong the QT interval
  • Gender identity guidance
  • Palpable cervical lymph nodes (paediatrics)
  • Ultrasound follow-up of gall bladder polyp
  • Vancomycin in haemodiafiltration

Updated guidance

  • Chronic and persistent pain

June 2023:

Updated guidance

  • Hyperkalaemia
  • FAQ for GP CT Referral for Cancer
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy
  • Ophthalmology referral guidelines, including Out of Hours
  • Ophthalmology emergency admission protocol: Raigmore and NTC
  • Orbital cellulitis
  • Lower limb lymphoedema
  • Upper Limb lymphoedema
  • Age-related macular degeneration (nhsh.scot)
  • Patient information - Stroke (nhsh.scot)
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy (nhsh.scot)
  • FAQ for GP CT Referral for Cancer Pathway (nhsh.scot)
  • Referral to Community Diabetes Specialist Nurses (nhsh.scot)

July 2023:

Updated guidance

  • Sayana Press
  • Armed forces and veterans 

August 2023:

New Guidelines

  • Major haemorrhage protocol 

Updated Guidelines 

  • Computerised cognitive behaviour (cCBT) 
  • Referral to community diabetes
  • FAQ for GP CT Referral for cancer pathway 
  • Imaging pathway for Primary Care direct access
  • Age related macular degeneration 
  • Patient information stroke 
  • Hyperkalaemia
  • Colorectal investigation and referral
  • Incorrect use of combined hormonal contraception 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke 
  • Adrenarche
  • Sleep onset difficulties 

September 2023:

New guidance:

  • Oral buprenorphine in opioid dependence (Guidelines) 
  • Medication assisted treatment (MAT) (Guidelines)
  • Serotonin syndrome (Guidelines)

Updated Guidance:

  • Malignant spinal cord compression
  • Uncomplicated chlamydia in Primary Care
  • Patient information stroke 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke
  • Management of children under 16yrs under the influence of drugs/alcohol 
  • Improving the Safety of Patients with a Tracheostomy
  • Ultrasound scan (USS) referral guidelines 

October 2023:

New guidance

  • Personality disorder integrated care pathway

Updated guidance

  • Prolonged seizure / status epilepticus in adults (Primary Care)
  • Osteoporosis
  • Computerised cognitive behavioural therapy (cCBT) 
  • Glucose monitoring
  • Red eye
  • Gender identity guidance 
  • Corticosteroids (dexamethasone, prednisolone and hydrocortisone for patients confirmed SARS-CoV-2 infection
  • Acute otitis media 
  • Acute otitis externa
  • Tuberculosis
  • Acute Coronary Syndrome
  • Emergency contraception 
  • Heart Failure assessment and investigations
  • Heat Failure diagnosis 
  • Heart Failure Medical management
  • Heart Failure Management of decompensation 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection
  • Lymphopenia assessment
  • ED Stroke Thrombolysis 
  • Ophthalmology referral guidelines, including Out of Hours 
  • Treatment COVID19
  • Antivirals and neutralising monoclonal antibodies COVID19
  • Hospital in-patient Tocilixumab and Sarilumab
  • Generalised anxiety disorder
  • Depression

November2023: 

Updated Guidance

  • Gender identity guidance (Guidelines) | Right Decisions (scot.nhs.uk)
  • Acute coronary syndrome
  • Highland Eating Disorder Service (HEDS) & Medical Emergency Eating Disorder (MEED)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Chronic Kidney Disease 
  • Acute Kidney Injury
  • Polycythaemia erythrocytosis
  • Psychotic Disorders
  • Thrombocytosis
  • Post-menopausal bleeding

December 2023: 

Updated Guidance

  • Feeling of lump in throat
  • Vascular
  • Treatment COVD19
  • Female urinary incontinence

2022

September 2022:

New guidance:

  • Short synacthen test
  • Resuscitation
  • Hypercalcaemia
  • Plasma metanephrines measurement
  • Delirium management
  • Child healthy weight
  • Faecal incontinence
  • Investigation of primary hyperaldosteronism

Updated guidance:

  • SGLT2 inhibitors type 2 diabetes

Guidance removed:

  • Toddler and young children; food, mood and health guidance

October 2022:

New guidance:

  • Colorectal secondary guidance

Updated guidance:

  • Testosterone replacement in menopause TAM492 
  • Gestational diabetes
  • Computerised cognitive behaviour (cCbt)
  • Folate testing and management
  • B12 deficiency testing and management
  • Children empirical antibiotic therapy
  • Intermittent claudication/critical ischaemia
  • Baricitinib for adults and children aged 2 years and older
  • Clostridium dificile
  • NTproBNP
  • Pre diabetes and type 2 diabetes referrals

Guidance removed:

  • Toddler and young children food mood and health guidance 

 

November 2022:

New guidance:

  • Bronchiolitis 
  • Emergency admission of adults with acute constipation
  • Groin hernia pathway 
  • Gallstone disease 
  • Anti reflux surgery

Updated guidance:

  • Amputation pain Raigmore
  • Ketamine
  • Teicoplanin
  • Gentamicin dosing in infective endocarditis in adults 
  • Naloxone and managing opioid
  • Post operative nausea and vomiting
  • Patient controlled analgesia PCA 
  • Subcutaneous opioid
  • Epidural analgesia
  • Local anaesthetic infusion
  • Wet legs lymphorrehoea

Guidance removed: 

  • None 

December 2022:

New Guidance: 

  • Silver Diamine fluoride
  • Bronchiolitis 
  • Raigmore emergency ophthalmology admission protocol

Updated Guidance: 

  • Pre diabetes and type 2 diabetes referrals
  • Testosterone replacement in menopause
  • Gentamicin
  • Subcutaneous Methotrexate
  • Highland eating disorder (HEDS) and MEED 
  • Subcutaneous opioids
  • Acute pain management in adults with renal impairment
  • Epidural analgesia 
  • Assessing vascular status
  • Wet legs lymphorrhoea
  • Ketamine infusion
  • Amputation
  • Pain assessment
  • Pain controlled analgesia
  • Post operative nausea and vomiting 
  • Naloxone and managing opioid
  • Local anaesthetic infusion 

Removed guidance: 

  • Information for patients, carers and families 
  • Treatment of medically unwell patients with anorexia nervosa 
  • MARSIPAN checklist 
  • Summary of a dieticians role 
  • Increased levels of care 

TEMPLATE FOR Latest updates

New Guidance:

  • Items will be added as published. 

Major updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.

  • Items will be added as published. 

Minor updates: 

To view the changes to the guidance, see the 'What's new' section of each guideline.
These items will be ratified at the next TAMSG. 


Reviewed with no changes: 

  • Items will be added as published. 

Removed Guidance:

  • Items will be added as removed.